Sort
261,768 grants matching “gene therapy”
Development of WecA-targeting immune potentiators to treat carbapenem-resistant Enterobacteriaceae (CRE) infections
$1,000,000Terry Roemer · Prokaryotics, Inc. · R44 · FY2021 · AI
Genetics of MRSA Infection
$1,000,000George M Weinstock · Washington University · RC2 · FY2010 · HG
Development of GPER Agonists as Cancer Therapeutics
$1,000,000Tina Garyantes · Linnaeus Therapeutics, Llc · R44 · FY2020 · CA
Hemophilia Point-of-Care Monitoring Device and App
$1,000,000Eugene Yan-Ho Chan · Dna Medicine Institute · R44 · FY2025 · HL
Improved Sirolimus-Analog Adventitial Delivery to Enhance Outcomes in Below-the-Knee Peripheral Artery Disease
$1,000,000Kirk Seward · Mercator Medsystems, Inc. · R44 · FY2025 · HL
Comparative Approach to the Hematopoietic Stem Cell
$1,000,000Children'S Hospital Boston · U01 · FY2002 · DK
Developing a bank of purified myeloid progenitor cells as a bridging therapy for transient pancytopenia resulting from radiation injury
$1,000,000Brian H. Johnstone · Ossium Health, Inc. · R44 · FY2025 · AI
Type III Secretion Inhibitors for Anti-Infective Therapy
$1,000,000Donald T Moir · Microbiotix, Inc · R44 · FY2011 · AI
Commercialization of an MRI contrast agent for differential diagnosis of prostate cancer
$1,000,000Yajuan Li · Molecular Theranostics, Llc · R44 · FY2022 · CA
Development of a stem-cell derived thymic cell therapy to treat patients with athymia
$1,000,000Bing Lim · Thymmune Therapeutics, Inc · R44 · FY2025 · AI
Monoclonal Antibody Cocktail for Treatment of Marburg Virus Disease
$1,000,000M. Javad Aman · Abvacc, Inc. · R44 · FY2025 · AI
Programming Metabolically Fit TILs for Immunotherapy
$1,000,000Shikhar Mehrotra · Lipo-Immuno Tech, Llc · R42 · FY2023 · CA
Plant-derived HIV neutralizing mAbs for passive immunotherapy in newborn macaques
$1,000,000Yvonne J Rosenberg · Plantvax, Inc. · R44 · FY2016 · AI
Development of a novel accurate therapy for multiple sclerosis
$1,000,000Gaddiel Galarza-Munoz · Autoimmunity Biologic Solutions, Inc. · R42 · FY2022 · AI
Human Stem Cell Model of Niemann Pick Type C
$1,000,000Lawrence S Goldstein · University Of California, San Diego · RC1 · FY2010 · NS
LIVER PATHOBIOLOGY AND GENE THERAPY RESEARCH CORE CENTER
$1,000,000Yeshiva University · P30 · FY2002 · DK
Commercializing Praedicare Dx TM platform for guiding cancer treatments
$1,000,000Michael H Cardone · Eutropics Pharmaceuticals, Inc. · R44 · FY2019 · CA
LIVER PATHOBIOLOGY AND GENE THERAPY RESEARCH CORE CENTER
$1,000,000Yeshiva University · P30 · FY2001 · DK
UCSC-Buck Inst. Genome Data Analysis Center for TCGA Research Network (GDAC)
$1,000,000David H Haussler · University Of California Santa Cruz · U24 · FY2014 · CA
Development of the NephroPlate: A high-throughput kidney-on-a-chip platform for identifying chronic kidney disease therapies
$1,000,000Kristin M Bircsak · Mimetas Us, Inc. · R44 · FY2022 · DK
Comparative Approach to the Hematopoietic Stem Cell
$1,000,000Children'S Hospital Boston · U01 · FY2003 · DK
Immunotherapy of MRSA Osteomyelitis
$1,000,000M. Javad Aman · Integrated Biotherapeutics, Inc. · R44 · FY2022 · AI
Development of a stem-cell derived thymic cell therapy to treat patients with athymia
$1,000,000Bing Lim · Thymmune Therapeutics, Inc · R44 · FY2024 · AI
Randomized Prospective Phase II Clinical Trial of NVX-108 in Association with Chemoradiation of Glioblastoma
$1,000,000Evan Charles Unger · Nuvox Pharma, Llc · R44 · FY2017 · CA
Exosomal Drug Delivery
$1,000,000Wendy A Spencer · 3p Biotechnologies, Inc. · R44 · FY2018 · CA